Research Team

Wangzhi Li, PhD

Managing Director, Equity Research-Biotech

Dr. Wangzhi Li covers small-to-mid cap biotech companies in oncology and other therapeutic areas. Prior to his current role, Dr. Li worked with Matt Kaplan in covering small-to-mid cap biopharma companies in oncology, endocrinology, nephrology, gastroenterology, ophthalmology, pain and drug delivery etc. Before joining in Ladenburg, Dr. Li worked in healthcare venture capital at Easton Capital and New York City Investment Fund. Dr. Li did his PhD research in cancer biology and epigenetics at Cold Spring Harbor Laboratory, New York and published multiple papers in Nature Communications, Epigenomics, Nature Cell Biology and Cell Stem Cell etc. Dr. Li received his bachelor's degree in biological science from Xiamen University, China.

Healthcare & Life Sciences

Matthew L. Kaplan

Matthew L. Kaplan

Managing Director, Head of Healthcare Equity Research

Jeffrey S. Cohen

Jeffrey S. Cohen

Managing Director, Equity Research

Wangzhi Li, PhD

Wangzhi Li, PhD

Managing Director, Equity Research-Biotech

Michael J. Higgins

Michael J. Higgins

Managing Director, Senior Biopharmaceuticals Equity Research

Yield-Oriented Equities

Mickey M. Schleien, CFA

Mickey M. Schleien, CFA

Managing Director, Equity Research

Christopher Nolan, CFA

Christopher Nolan, CFA

Executive Vice President, Equity Research

Energy, Power & Infrastructure

Michael C. Schmitz, CFA

Michael C. Schmitz, CFA

Managing Director, Equity Research

Telecom, Media & Technology

Jon R. Hickman

Jon R. Hickman

Managing Director, Equity Research

Glenn G. Mattson, Jr.

Glenn G. Mattson, Jr.

Vice President, Equity Research